University of Thessaly (UTH)
Μελέτη πολυμορφισμών των γονιδίων των κυτταροκινών σε ασθενείς με σκλήρυνση κατά πλάκας
Abstract
dc:descriptionINTRODUCTION Multiple Sclerosis (MS) is an autoimmune, inflammatory and demyelinating, chronic disorder of the Central Nervous System (CNS) and although its cause is unknown, it is thought to be an interplay between genetic and environmental factors. Interleukin (IL) 1β (IL-1β) is a pro-inflammatory cytokine with pleiotropic activities including mainly growth and differentiation of T- and B-cells. In MS, it is expressed by many cell types including macrophages and microglia within MS lesions and is considered to participate actively in the appearance of demyelinating lesions in CNS. Its activity is inhibited by the IL-1 receptor antagonist (IL-1Ra), which blocks the biological activity of IL-1b, not only in normal, but also in pathophysiological immune and inflammatory response, by preventing the activation of the target cells. IL-2 is one of the crucial immunoregulatory cytokines, and has both pro-inflammatory and anti-inflammatory actions, promoting T-cell proliferation during all mediated responses. OBJECTIVE The aim of the present study was to investigate, for the first time in Greek patients with MS, the possible association of specific polymorphisms of the IL-1Β (TaqI +3953 C/T, within the fifth exon and AvaI -511 C/T, in the promoter region), IL-1RN (a variable number of tandem repeats, VNTR, within the second intron) and IL-2 (MwoI +114 G/T, within the first exon and BfaI -384 G/T, in the promoter region) genes with both the susceptibility to and the clinical characteristics of the disease. MATERIALS AND METHODS Genotypes were determined from 397 consecutive patients with clinically definite MS and 375 matched to age and sex healthy controls of Greek origin from the Larissa region. All patients were diagnosed, as suffering from MS, at the Department of Neurology, at University Hospital of Larissa, according to the latest international guidelines. Disability was assessed using the Kurtzke Expanded Disability Status Scale (EDSS). To evaluate the disability indexed to time, we used the Multiple Sclerosis Severity Score (MSSS). Patients with relapsing-remitting (RR) and secondary progressive (SP) type of MS were classi?ed together as “bout-onset” and we a priori decided to genotype only them, as they constituted the big majority of patients (n=351). Polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP) and agarose gel electrophoresis techniques were used to determine the above polymorphisms. RESULTS AND CONCLUSIONS Our present ?ndings suggest that these polymorphisms make no major contribution to susceptibility or disease severity of MS patients in central Greece.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Aggelakis, Konstantinos
- Αγγελάκης, Κωνσταντίνος
Subjects
dc:subject × 22- Σκλήρυνση κατά πλάκας
- Παροξυσμικής έναρξης μορφή της νόσου
- Πολυμορφισμοί
- Ιντερλευκίνη-1Β
- Ιντερλευκίνη-2
- Ανταγωνιστής του υποδοχέα της ιντερλευκίνης 1
- Αλυσιδωτή αντίδραση πολυμεράσης
- Πολυμορφισμός μήκους περιοριστικών θραυσμάτων
- Μελέτη συσχέτισης
- Multiple sclerosis
- Bout onset type of the disease
- Polymorphisms
- Interleukin-1B
- Interleukin-2
- Interleukin 1 receptor antagonist
- Polymerase chain reaction (PCR)
- Restriction fragment length polymorphism (RFLP)
- Association study
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25033